According to Zacks, “Revlon, Inc. conducts its business exclusively through its subsidiary, Revlon Consumer Products Corp. and its subsidiaries. They manufacture, market and sell an extensive array of cosmetics and skin care, fragrances and personal care products. Their brand names are REVLON, COLORSTAY, REVLON AGE DEFYING, ALMAY and ULTIMA II in cosmetics; MOON DROPS, ETERNA 27, ULTIMA II and JEANNE GATINEAU in skin care; CHARLIE and FIRE & ICE in fragrances; and FLEX, OUTRAGEOUS, MITCHUM, COLORSTAY, COLORSILK, JEAN NATE, PLUSBELLE, BOZZANO and COLORAMA in personal care. “
Separately, ValuEngine lowered Zosano Pharma from a buy rating to a hold rating in a research report on Wednesday, May 1st.
Revlon (NYSE:REV) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($1.20) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.73) by ($0.47). The business had revenue of $553.20 million during the quarter, compared to analyst estimates of $553.60 million. The business’s revenue was down 1.3% compared to the same quarter last year. As a group, equities analysts anticipate that Revlon will post -2.76 earnings per share for the current year.
In other Revlon news, Director Ronald O. Perelman acquired 140,000 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were purchased at an average cost of $21.34 per share, for a total transaction of $2,987,600.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Ronald O. Perelman acquired 20,000 shares of the business’s stock in a transaction dated Friday, June 7th. The stock was acquired at an average price of $23.51 per share, for a total transaction of $470,200.00. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 240,000 shares of company stock worth $5,231,000. Corporate insiders own 85.00% of the company’s stock.
Several hedge funds have recently modified their holdings of the company. Quantamental Technologies LLC bought a new stake in shares of Revlon during the first quarter valued at approximately $25,000. BNP Paribas Arbitrage SA boosted its position in shares of Revlon by 428.6% during the first quarter. BNP Paribas Arbitrage SA now owns 1,924 shares of the company’s stock valued at $37,000 after purchasing an additional 1,560 shares in the last quarter. CenterStar Asset Management LLC bought a new stake in shares of Revlon during the first quarter valued at approximately $49,000. Advisory Services Network LLC bought a new stake in shares of Revlon during the fourth quarter valued at approximately $131,000. Finally, Bank of America Corp DE boosted its position in shares of Revlon by 9.9% during the fourth quarter. Bank of America Corp DE now owns 5,494 shares of the company’s stock valued at $139,000 after purchasing an additional 493 shares in the last quarter. Hedge funds and other institutional investors own 13.48% of the company’s stock.
Revlon Company Profile
Revlon, Inc, through its subsidiaries, develops, manufactures, markets, distributes, and sells beauty and personal care products worldwide. The company's Relvon segment offers color cosmetics and beauty tools under the Revlon brand; and hair color under the Revlon ColorSilk and Revlon Professional brands.
Featured Story: What are the risks of holding treasury bonds?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Revlon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revlon and related companies with MarketBeat.com's FREE daily email newsletter.